Richard Labaudiniere

Advisor at ViewPoint Therapeutics

Richard is the former CEO and President of FoldRx, a company focused on protein misfolding diseases, which was acquired by Pfizer in 2010. Richard has deep expertise in medicinal chemistry.

Org chart

Stan Prusiner

Advisor

Teams

Board of Directors

2 members

Timeline

  • Advisor

    Current role